Motesanib diphosphate
Motesanib Diphosphate
Motesanib Diphosphate (pronunciation: moe-TES-a-nib dye-FOS-fate) is a type of antineoplastic agent that is used in the treatment of certain types of cancer. It is a small molecule inhibitor that targets multiple receptor tyrosine kinases.
Etymology
The name "Motesanib" is derived from the chemical structure of the drug. "Mote" is a reference to the drug's ability to target multiple sites, while "sanib" is derived from the Latin word "sanus", meaning healthy. The "diphosphate" part of the name refers to the chemical compound that the drug is combined with to increase its stability and effectiveness.
Mechanism of Action
Motesanib Diphosphate works by inhibiting the activity of certain proteins called receptor tyrosine kinases that play a key role in the growth and spread of cancer cells. By blocking these proteins, the drug can help to slow down or stop the growth of the cancer.
Related Terms
- Antineoplastic agent: A type of drug that is used to kill cancer cells.
- Receptor tyrosine kinase: A type of protein that is involved in the growth and spread of cancer cells.
- Small molecule inhibitor: A type of drug that can block the activity of certain proteins in the body.
See Also
External links
- Medical encyclopedia article on Motesanib diphosphate
- Wikipedia's article - Motesanib diphosphate
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski